Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in Infants

Summary

A randomized, double-blind, phase II-02 clinical trial is to evaluate the safety and immunogenicity of an inactivated EV71 vaccine with or without aluminum adjuvant

Timeline

Start

2011-09

Primary completion

2011-11

Completion

2011-12

Outcome

Outcome not reported

Stopped: “Based on the previous study results, inactivated EV71 vaccine with aluminum adjuvant was elected to be used for the efficacy Phase III study.”

Drugs

Indications